Results - Financial Results For Year Ended 31 March 2026
Filed with BSE · · 8 pages · English
Summary by 6ix AI
Additionally, the board has recommended a final dividend for the financial year, pending shareholder approval at the upcoming annual general meeting. The filing also details the reappointment of Mr. Cyrus Poonevala as an independent director for a second term, subject to shareholder approval.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
This is to inform you that the Board of Directors of the Company at its meeting held today i.e. on 13th May 2026, approved the following: 1. Audited Financial Results for the quarter and year ended 31st March 2026. Audited financial results for the quarter and year ended 31st March 2026 and Auditors Report issued by CNK & Associates LLP, Statutory Auditor of the Company are enclosed. 2. Recommende
Sunshield Chemicals Limited on 6ix
Earlier from Sunshield Chemicals
- Board Meeting Outcome for Outcome Of Board Meeting
- Sunshield Chemicals Limited Press Release Apr 23 2026
- Board Meeting Intimation for Audited Financial Results For The Year Ended 31St March 2026 And Recommendation Of Dividend, If Any, For Financial Year Ended 31St March 2026
- Sunshield Chemicals Limited Press Release Mar 30 2026
- Announcement under Regulation 30 (LODR)-Credit Rating
Later from Sunshield Chemicals
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Corporate Action-Board approves Dividend
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Sunshield Chemicals Limited Press Release May 13 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Follow Sunshield Chemicals into a list and get an email when it puts out news.
Follow Sunshield Chemicals